Menu
The well-curated programs and learning resources crafted by experts are aimed to keep you updated with the latest advancements, discoveries, and scientific breakthroughs.
We are a team of dedicated experts from academia, research, and industry with several years of experience. We constantly challenge ourselves to strive, to keep improving, and create innovative ideas that can make your learning experience a memorable one.
All our courses are CPD accredited and you would receive a certificate upon successful completion that is globally acknowledged. This implies that you not only learn out also add value to your curriculum vitae.
World-class learning from the comfort of your space and time.
The CBEHx platform is a pioneering business in online education in various scientific disciplines for students, scientists, academicians, industry professionals, organisations, and others across the globe.
The programs and learning resources offered are flexible to suit your daily schedule, affordable with competitive pricing, and fun with integrated multimedia to make your learning experience unique and unforgettable.
The e-learning courses and other resources are career-targeted to help you succeed in your career and to stay ahead with the latest scientific discoveries and breakthroughs.
CBEHx believes that the world’s best instructors are not just only confined within classrooms.
Innovation to enhance the productivity and efficiency of the team
Strategic partnership with institutes and organisations
Create programs, and learning resources with high customer perceived value
Customer-friendly outlook and respect customer reviews and feedback
Foster mutually collaborative culture among its employees
Promote positive workplace culture
Our team comprises of highly-qualified experts from different countries with several years of research and technical experience in their own fields.
Founder & CEO
Scientific & Medical Illustrator
Scientific & Medical Illustrator
Senior Scientific Writer
Graphic Designer
Instructor
Instructor
Instructor
Instructor
Instructor
Instructor
Instructor
Instructor
Instructor
Instructor
Instructor
Instructor
Instructor
Instructor
Instructor
Martina Fabricci, MSc, MBA, is the founder of CRISPR Biotech Engineering (CBE) and the CBEHx platform. She has a strong background in science with years of experience in the investment sector focussing on biotechnology.
Her pioneering efforts in women empowerment and contribution towards the United Nations Sustainable Development Goal (UNSDG) of providing quality STEM education have been globally appreciated. She strongly supports the elimination of gender disparity in education and aims to provide quality education at an affordable price to students, scientists, academicians, industry professionals, and others worldwide. She aims to improve learning opportunities for all, irrespective of their socioeconomic background and believes that education can drive socioeconomic development.
Within a short span of time in her career, she has received several awards and accolades. As the founder and director of CBE, Martina has received the ‘Woman Who Achieves Awards’ in the Start-up of the Year category and the ‘Woman Business Conference Awards’ for the Innovation Category. She has also been selected as the finalist for the SME National Business Awards as Young Business Person of the Year. She has been able to carve a niche for herself in a domain that is still believed to be male-dominated. CBE has been nominated for several awards and has been selected as the finalist in several others, including the ‘Great British Entrepreneur Awards’, ‘Wales StartUp Awards’ as Medtech StartUp of the year.
Henrique has a Ph.D. in computational and theoretical chemistry from the University of Porto in Portugal. He studies enzymatic mechanism using computational methodologies to obtain complete descriptions of catalytic mechanisms with atomistic level of detail. These techniques provide valuable insights for the rational drug design and enzyme engineering. He has also more than 5 years of experience in software development and scientific illustration and animation.
Ph.D. in Biotechnology and Plant Science with BSc in Chemistry, Physics and Mathematics and a Master’s in Biotechnology specialized in Synthetic Biology. Currently, I am investigating the role of strigolactones in plant development and as a host-recognition signal used by the parasitic plant Striga by studying CRISPR-mediated genome engineered rice. Besides my research, I help researchers and companies to promote science to a broader audience using visuals.
PhD in Chemical Sciences from IISER-K India, with postdoctoral research experience in Chemical Biology from the University of Manchester. The research work involved development of glycan arrays for high-throughput screening of pathogens and biomarker discovery. Thereafter, Amrita have worked at Mylan Laboratories Ltd as an assistant manager in the development of parenterals.
John graduated from the faculty of Engineering and Technology in University of Ilorin. He is a passionate self-taught graphic designer with the passion and enthusiasm for his work which has shone through, working locally and internationally, in the design and advertising industry. He works hard to combine marketing talent, exceptional design, and technology with outstanding customer service to build long-term partnerships, deliver value, and evolve with brands. He is an expatriate in business branding, motion graphics, corporate brand identity using a graphic-analytic approach to generate solutions through creative means.
Ph.D. in Cancer Biology, Division of Molecular and Clinical Cancer Sciences, University of Manchester, UK. Areas of expertise include cancer immunology, melanoma research, cancer immunotherapy, and mechanisms of immunotherapy resistance. During my Ph.D. research, I studied the role of chronic inflammation and cytokine IFN-gamma in adaptation and immunotherapy resistance in melanoma. By integrating high-throughput transcriptomic analyses and employing various cancer cell lines and animal models, I have developed methods to predict response to immunotherapy in melanoma patients. During my research, I have used the CRISPR/Cas9 system to knockout genes in human and mouse cell lines to assess the role of certain genes in immunotherapy resistance in melanoma.
Corrado holds a Ph.D. in molecular epidemiology from Liverpool University, U.K. He trained and conducted research in parasitology and medical entomology at the Liverpool School of Tropical Medicine. He developed strong expertise in the epidemiology and molecular diagnostics of parasitic and vector-borne infections, both in the lab and in the field in developing countries. He also has a strong interest in public health microbiology training, medical education, and science communication.
Alison is a marine biologist with a Ph.D. in marine science from the King Abdullah University of Science and Technology in Saudi Arabia. She studies the effect of climate change on marine organisms, specifically those that live in threatened coral reef ecosystems. Her recent work uses molecular tools such as transcriptomics and proteomics to research how fish might acclimate to future climate scenarios. She spent much of the past 6 years exploring the beautiful and diverse coral reefs of Saudi Arabia and helped document one of the first mass coral bleaching events in the Red Sea.
Illida has always been passionate about sharing her knowledge and mentoring students with their research projects. She obtained her degree in Biomedical Engineering (concentration in Biomaterials and Tissue Engineering) from the Case Western Reserve University, USA. After graduating, she pursued her studies in the design and validation of a novel-designed mechanical cell bioreactor and later earned M.Sc. in Biomedical Engineering from the University of Malaya, Malaysia. This is also where she acquired four years of teaching experience. Besides teaching, Illida also gained experience in designing laboratory modules and supervising and training undergraduate and postgraduate students in research technical skills. Later on, she moved to Manchester where she was awarded her Ph.D. from the University of Manchester for her research in regenerating cartilage in peptide hydrogels.
Sherif holds a M.Sc. in Pharmacology from the University of Oxford UK and a Ph.D. in Neuroscience from the University of Lübeck, Germany. During his Ph.D., he studied the role of astrocytes in energy homeostasis and obesity and novel methods of primary astrocyte culture. His work has been published in journals such as Frontiers and Neuropsychopharmacology. After his Ph.D., he moved to the University of Bern, Switzerland for postdoctoral studies on new innovative therapies in multiple sclerosis.
Dr. Alice Hamilton gained a 1st class BSc in Biomedical Sciences in 2015 from the University of Dundee. She then joined the William Harvey Institute Queen Mary University of London where in 2016 she gained a M.Res. in Inflammation: Cellular and Vascular Aspects and in 2020 she gained a Ph.D. in cardiovascular pathophysiology. Her doctoral thesis was titled ‘The Effect of Social Isolation on the Immune System’.
Alice holds a Ph.D. in Neuropharmacology from Heidelberg University, Germany. During her Ph.D., she mainly studied the contribution and specificity of primary sensory neurons involved in acute pain signalling. After her Ph.D., she moved to London and focused on neurodevelopment at King’s College London. She developed strong expertise in neurophysiology, optogenetics, immunohistochemistry, and animal behaviour. Her work has been published in peer-reviewed scientific journals including Neuron, a well-established journal in the field of neuroscience.
Ph.D. in Microbiology, University of Chemistry and Technology, Czech Republic. During and after her Ph.D., she participated in projects on microbial interactions with nanofibers, biofilm formation, and quorum sensing. Her major research concerned human pathogens Campylobacter spp. She developed protocols of molecular-genetic techniques for their identification, quantification, and phenotype and genotype characterisation. She focused on determining the limits of such methods including the issue of eliminating signals coming from dead cells, and how the mode of death influences results. She has strong expertise in microbiology and molecular genetics and following the internship in Vienna also strong interest in bioinformatics, and microbiomes.
Dr. María Banqueri majored in Psychology at Granada University in 2013 and completed her M.Sc. in Cognitive Neuroscience in 2014. She conducted a Ph.D. at Oviedo University and an internship at Roslin Institute (Edinburgh University) about the psychobiological effects of early stress, during these four years she lectured at the Psychology faculty. In 2019 she moved to Warsaw to work as a postdoc in Molecular Neurobiology at Nencki Institute where she is finishing a project about the microglial role in major depressive disorders. During this last postdoc, she collaborated with La Sapienza University in Rome. She has published 11 scientific papers and 5 book chapters and shared scientific results in meetings and congresses more than 20 times.
Mai holds a Ph.D. in Cancer Metabolism from the University of the West of England, UK. Her Ph.D. focused on dysregulated cell metabolism in particular the role of branched-chain aminotransferase proteins in the progression of breast cancer. Her work has been published in peer-reviewed scientific journals including Oncotarget. After her Ph.D., she moved to Sheffield for a post-doctoral research position at the University of Sheffield investigating mechanisms by which epithelial tissues shape and polarize using the mammary gland as a model system. She has developed strong expertise in biochemistry, breast cancer, cell biology, and cell signalling pathways.
Eléonore is a Ph.D. graduate in Medicine from the University of Cambridge. Her doctoral research focussed on respiratory diseases and intensive care. She has recently conducted a clinical research project on COVID-19 to analyse how the virus affects various types of immune cells in human blood. Prior to her completing her Ph.D., Eléonore has worked in cancer research for 4 years, both at the Dana Farber Cancer Institute of Harvard University and the Rosalind and Goodman Research Center at McGill University. She also has experience of working in a pharmacological company, having worked for the Global Research and Development Department of Pfizer.
Ph.D. in Immunology at the Division of Immunopharmacology of the University Clinic of Frankfurt am Main. Involved in basic and applied research for immunological interventions to treat cancer for 13 years. Matthias used a high-throughput CRISPR/Cas9 approach to generate a library of knockout cells that could be differentiated into immunosuppressive cells to investigate the potential loss of function situations. Currently involved in the development of fusion proteins to activate receptors of the TNF-superfamily (CD40, CD27, etc.) at a small German Biotech company as Head of Assay Development.
Dr. Roushanak Rahmat is an AI research scientist with research interests in medical imaging and cancer research. She was working on deep learning modeling for early detection of lung cancer at the Institute of Cancer Research (ICR), London. Before joining ICR, she was researching at the department of Neurosurgery, University of Cambridge, and the School of Computer Science of St. Andrews University. She obtained her Ph.D. in Electrical, Electronics, and Computer Engineering at Heriot-Watt University.
Sterling has a Ph.D. in Machine Learning from The University of the West Indies. He moved to London after his Ph.D. to pursue a Computer Vision Researcher position in the industry. His Ph.D. research focused on accelerating machine learning techniques with parallel processing and applying it to bioinformatics. His work is published in peer-reviewed scientific journals including Molecular Omics, Expert Systems with Application, and BMJ Innovations.
Veronica Hughes received her Ph.D. in medical science from the University of Florida. Her primary interest was cancer metastasis, dysregulation of the tumour microenvironment, and analysis of clinical trial design. Additionally, she engaged in the development of novel small animal models.
Vytautas holds MSc and Ph.D. in Cognitive Psychology from the University of Hull and Bishop Grosseteste University. His main interest lies in human cognition and memory, and how technology such as virtual reality can be employed to help research those subjects. The majority of his research involves programming and creating custom virtual environments which he uses to obtain the needed behavioural data.
